Our data suggest that the astrocytic response, as indicated by elevated plasma GFAP levels, may play a protective role against cognitive deterioration, as these levels were very high in cognitively preserved nonagenarians and occurred in the absence of significant markers of AD pathology. Here, GFAP is linked to Alzheimer disease.